La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Micro-X Résultats passés
Passé contrôle des critères 0/6
Micro-X's earnings have been declining at an average annual rate of -4.3%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 44.1% per year.
Informations clés
-4.3%
Taux de croissance des bénéfices
27.7%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 5.8% |
| Taux de croissance des recettes | 44.1% |
| Rendement des fonds propres | -145.6% |
| Marge nette | -95.6% |
| Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Take Care Before Diving Into The Deep End On Micro-X Limited (ASX:MX1)
Jun 24
Micro-X Limited (ASX:MX1) Doing What It Can To Lift Shares
Mar 12Sentiment Still Eluding Micro-X Limited (ASX:MX1)
Jul 14Is Micro-X (ASX:MX1) In A Good Position To Invest In Growth?
May 02Shareholders May Not Be So Generous With Micro-X Limited's (ASX:MX1) CEO Compensation And Here's Why
Nov 07We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully
Jul 07Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation
Mar 01What We Learned About Micro-X's (ASX:MX1) CEO Pay
Jan 29What Kind Of Shareholders Hold The Majority In Micro-X Limited's (ASX:MX1) Shares?
Jan 08Have Insiders Been Buying Micro-X Limited (ASX:MX1) Shares?
Dec 18
Micro-X Limited's (ASX:MX1) Shift From Loss To Profit
Nov 27Ventilation des recettes et des dépenses
Comment Micro-X gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 23 | 15 | -15 | 19 | 3 |
| 30 Sep 23 | 15 | -13 | 19 | 2 |
| 30 Jun 23 | 15 | -11 | 19 | 0 |
| 31 Mar 23 | 15 | -11 | 19 | -3 |
| 31 Dec 22 | 15 | -12 | 18 | -3 |
| 30 Sep 22 | 12 | -15 | 18 | -2 |
| 30 Jun 22 | 9 | -17 | 18 | 0 |
| 31 Mar 22 | 6 | -18 | 17 | 0 |
| 31 Dec 21 | 4 | -19 | 17 | 0 |
| 30 Sep 21 | 4 | -17 | 14 | 0 |
| 30 Jun 21 | 4 | -15 | 12 | 0 |
| 31 Mar 21 | 5 | -13 | 10 | 0 |
| 31 Dec 20 | 6 | -11 | 8 | 0 |
| 30 Sep 20 | 5 | -10 | 8 | 0 |
| 30 Jun 20 | 4 | -10 | 8 | 0 |
| 31 Mar 20 | 3 | -9 | 8 | 0 |
| 31 Dec 19 | 2 | -8 | 7 | 0 |
| 30 Sep 19 | 2 | -9 | 7 | 0 |
| 30 Jun 19 | 2 | -10 | 7 | 0 |
| 31 Mar 19 | 2 | -14 | 7 | 0 |
| 31 Dec 18 | 2 | -18 | 6 | 0 |
| 30 Sep 18 | 2 | -17 | 6 | 0 |
| 30 Jun 18 | 2 | -17 | 6 | 0 |
| 31 Mar 18 | 1 | -14 | 5 | 0 |
| 31 Dec 17 | 1 | -11 | 5 | 0 |
| 30 Sep 17 | 1 | -12 | 4 | 0 |
| 30 Jun 17 | 1 | -13 | 4 | 0 |
| 31 Mar 17 | 1 | -13 | 4 | -4 |
| 31 Dec 16 | 1 | -13 | 3 | -8 |
| 30 Sep 16 | 1 | -12 | 3 | -4 |
| 30 Jun 16 | 1 | -11 | 2 | 0 |
| 31 Mar 16 | 1 | -12 | 1 | 6 |
| 31 Dec 15 | 0 | -13 | 1 | 13 |
| 30 Sep 15 | 0 | -11 | 1 | 10 |
| 30 Jun 15 | 0 | -10 | 0 | 7 |
Des revenus de qualité: MX1 is currently unprofitable.
Augmentation de la marge bénéficiaire: MX1 is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: MX1 is unprofitable, and losses have increased over the past 5 years at a rate of 4.3% per year.
Accélération de la croissance: Unable to compare MX1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: MX1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendement des fonds propres
ROE élevé: MX1 has a negative Return on Equity (-145.6%), as it is currently unprofitable.